Live Breaking News & Updates on Tight Junction Modulation

Stay updated with breaking news from Tight junction modulation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Tarrytown, NY and New York, NY, Dec. 27, 2023 Visiox Pharmaceuticals, Inc. , a commercial-stage biopharmaceutical company, and PowerUp Acquisition Corp. today announced the execution of a. ....

New York , United States , Ryans Bleeks , Visiox Powerup , Suren Ajjarapu , Ryan Bleeks , Dykema Gossett , Surendra Ajjarapu , Nelson Mullins Riley Scarborough , Visiox Holdings Inc , Powerup Acquisition Corp , Sun Pharma Advanced Research Company Ltd , Visiox Pharmaceuticals Inc , Globenewswire Inc , Exchange Commission , Nasdaq Capital Market , New Chemical Entity , Tight Junction Modulation , Sun Pharma Advanced Research Company , Visiox Pharma , Chief Executive , Information About , Proposed Business Combination , Current Report , Business Combination , Street Unit ,

Visiox Pharma Licenses OMLONTI®

/PRNewswire/ Visiox Pharma, Inc., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to. ....

United States , Ryans Bleeks , Ryan Bleeks , Visiox Pharma , Santen Pharmaceutical Co Ltd , Drug Administration , Visiox Pharma Inc , Eye Diseases Prevalence Research Group , Sun Pharma Advanced Research Company Ltd , New Chemical Entity , Chief Executive , Tight Junction Modulation , Sun Pharma Advanced Research Company , Prevent Blindness , Ocular Surgery Procedures , Market Scope ,

Visiox Pharma Expands Executive Team with the Appointment of Sanjay Malieckal as Vice President of Sales and Marketing

/PRNewswire/ Visiox Pharmaceuticals, Inc., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs. ....

United States , Ryan Bleeks , Ryans Bleeks , Sanjay Malieckal , Visiox Pharmaceuticals Inc , Eye Diseases Prevalence Research Group , Sun Pharma Advanced Research Company Ltd , Prnewswire Visiox Pharmaceuticals Inc , Eyepoint Pharmaceuticals , Vice President , Chief Executive , Sun Ophthalmics , Tight Junction Modulation , Sun Pharma Advanced Research Company , Visiox Pharma , Prevent Blindness , Surgery Procedures , Market Scope ,

Visiox Pharma Announces FDA Acceptance of New Drug Application for Glaucoma

/PRNewswire/ Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to. ....

Ryans Bleeks , Ryan Bleeks , Prnewswire Visiox Pharma , Drug Administration , Sun Pharma Advanced Research Company Ltd , Visiox Pharma , New Drug Application , Prescription Drug User Fee Act , Chief Executive , Tight Junction Modulation , Sun Pharma Advanced Research Company , Surgery Procedures , Market Scope , Visiox Pharma Llc , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Fda Approval ,

Visiox Pharma Appoints Industry Veteran Cynthia Matossian, M.D., as Chief Medical Officer

/PRNewswire/ Visiox Pharma, LLC., a privately funded biopharmaceutical company focused on the development and commercialization of ophthalmic drugs to. ....

New York , United States , Cynthia Matossian , Ryans Bleeks , Ryan Bleeks , Visiox Pharma , Prnewswire Visiox Pharma , Matossian Eye Associates , Pennsylvania State University College Of Medicine , Sun Pharma Advanced Research Company Ltd , George Washington University School Of Medicine , American College Of Eye Surgeons , Hershey Medical Center , Chief Medical , Chief Executive , Chief Medical Officer , Medical Director , Ophthalmology Power List , American College , Eye Surgeons , Board Member , Pennsylvania State University College , George Washington University School , New Drug Application , Tight Junction Modulation , Sun Pharma Advanced Research Company ,